NCT04539847

Brief Summary

The study aims to investigate if the level of hearing aid (HA) technology has an impact on self-reported outcomes in patients with presbycusis in terms of overall IOI-HA scores, Factor 1, Factor 2 scores, SSQ scores, and the SSQ domains. The study explores if presbycusis patients report better outcomes with premium level HA technology compared to basic level HA technology. Further, the study investigates if premium level HAs provide more high-frequency gain than basic HAs using Real Ear Measurements.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
208

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

August 31, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 7, 2020

Completed
Last Updated

October 20, 2020

Status Verified

June 1, 2020

Enrollment Period

1.4 years

First QC Date

August 31, 2020

Last Update Submit

October 19, 2020

Conditions

Keywords

hearing aid technologypresbycusisself-reported outcome measures

Outcome Measures

Primary Outcomes (2)

  • International Outcome Inventory for Hearing Aids

    Hearing aid benefit questionnaire that consists of seven questions targeting different outcome domains. Each question is scored on a scale from 1 to 5 where a higher score indicates a better outcome.

    two months

  • Speech, Spatial, and Quality of hearing scale (the short form)

    Hearing aid benefit questionnaire that consists of 12 questions targeting the hearing ability in different situations. Each question is ranked on a scale from 0 to 10 where a lower score indicates a greater disability.

    two months

Study Arms (2)

High-end hearing aid

EXPERIMENTAL

Patients will be fitted with premium level hearing aid technology

Device: High-end hearing aid

Basic hearing aid

EXPERIMENTAL

Patients will be fitted with basic level hearing aid technology

Device: Basic hearing aid

Interventions

hearing aid with premium level of technology

Also known as: Oticon, Resound, Widex
High-end hearing aid

hearing aid with basic level of technology

Also known as: Oticon, Resound, Widex
Basic hearing aid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with presbycusis

You may not qualify if:

  • Not being able to fill out questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Houmoller SS, Wolff A, Tsai LT, Narayanan SK, Hougaard DD, Gaihede ML, Neher T, Godballe C, Schmidt JH. Impact of hearing aid technology level at first-fit on self-reported outcomes in patients with presbycusis: a randomized controlled trial. Front Aging. 2023 Jun 1;4:1158272. doi: 10.3389/fragi.2023.1158272. eCollection 2023.

MeSH Terms

Conditions

Presbycusis

Condition Hierarchy (Ancestors)

Hearing Loss, SensorineuralHearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jesper H Schmidt, PhD, MD

    Odense University Hospital, Region of Southern Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two-arm parallel assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2020

First Posted

September 7, 2020

Study Start

December 1, 2016

Primary Completion

May 1, 2018

Study Completion

May 1, 2018

Last Updated

October 20, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

All personal data will become anonymized and handled with full confidentiality in compliance with the Personal Data Processing Act and GDPR. The procedure of personal data processing will be reported to the Danish Data Protection Agency (Datatilsynet) in Odense University Hospital, Region of Southern Denmark.